Stock info Core Laboratories | Filter Basic-Info
Stock: Core Laboratories (Amsterdam local), ISIN: NL0000200384
| Last Price | 11.51 | Max Price | 21.61 |
| Min Price | 10.29 | 1 Year return | -33.51 |
| Avg. Target | 0.00 | Expected Return | -100.00 % |
| Sector | Industry | Subsector | Oil & Gas producers |
| Sell | 0 | Rating | |
| Hold | 0 | Concensus | |
| Buy | 0 | ||
| Annual report 2018 |
Loading...
Sector Review Core Laboratories
Loading...
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 596 | 2,365,193 | 0.03 % |
| 2020 | 399 | 1,441,308 | 0.03 % |
| 2021 | 414 | 2,394,794 | 0.02 % |
| 2022 | 458 | 3,436,716 | 0.01 % |
| 2023 | 462 | 3,037,819 | 0.02 % |
Advice Core Laboratories
| Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
|---|---|---|---|---|---|
| April 30, 2015 | ING | Core Laboratories | Hold |
News Core Laboratories
Analysts expect over 2021 decreasing revenue Core Laboratories
Tomorrow Core Laboratories will publish it's past quarters results. For this year the company, located in Amsterdam revenue will be around 479.8 million euros. This is according to the average of the analysts' estimates. This is slightly lower than 2020's revenue...
Analysts expect over 2018 rising revenue Core Laboratories, high dividend yield
Tomorrow Core Laboratories will publish its past quarters results. For this year Core Laboratories's revenue will be around 701,68 million euros. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 659,81 million...
Analysts expect over 2017 rising revenue Core Laboratories
Tomorrow the Dutch Core Laboratories will publish her past quarter's figures. For this year Core Laboratories 's revenue will be around 690,11 million Euro. This is according to the average of the analysts' estimates. This is rather significant more than 2016's...
Annual reports Core Laboratories
| 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
Profile Core Laboratories
No Records Found
Results Core Laboratories
| Results |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Revenue |
|
|
|
|
|
| Costs |
|
|
|
|
|
| Profit |
|
|
|
|
|
| Margin of profit |
|
|
|
|
|
| ROI |
|
|
|
|
|
Balance Core Laboratories
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
Details Core Laboratories
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
120.04
|
109.55
|
59.66
|
37.67
|
26.51
|
| Eps |
1.39
|
1.57
|
1.56
|
2.04
|
-1.80
|
| Price/earnings-ratio |
86.36
|
69.78
|
38.24
|
18.47
|
-6.39
|
| Dividend |
2.09
|
1.83
|
1.92
|
1.96
|
0.23
|
| Dividend % |
1.74 %
|
1.67 %
|
3.22 %
|
5.20 %
|
2.00 %
|
| Payout % |
1.50
|
1.17
|
1.23
|
0.96
|
-0.13
|
| Book value |
3.26
|
2.73
|
3.08
|
3.57
|
1.31
|
| Market to book |
0.03
|
0.02
|
0.05
|
0.09
|
0.11
|
| Cashflow per stock |
2.84
|
2.34
|
2.20
|
1.80
|
1.06
|
| Stocks |
44
|
44
|
44
|
44
|
45
|
| Market Cap |
5.299.92
|
4.840.38
|
2.643.94
|
1.675.02
|
513.03
|
Dividend Core Laboratories
Price info Core Laboratories
|
Date
|
Price
|
|---|---|
|
01 Sep 2025
|
11.51
|
|
21 Aug 2025
|
10.34
|
|
15 Aug 2025
|
10.60
|
|
07 Aug 2025
|
10.29
|
|
23 Jul 2025
|
11.77
|
|
18 Jul 2025
|
11.40
|
|
17 Jul 2025
|
11.65
|
|
16 Jul 2025
|
11.32
|
|
15 Jul 2025
|
11.68
|
|
14 Jul 2025
|
12.44
|
|
11 Jul 2025
|
12.86
|
|
10 Jul 2025
|
12.94
|
|
09 Jul 2025
|
12.57
|
|
08 Jul 2025
|
12.78
|
|
07 Jul 2025
|
12.23
|
|
03 Jul 2025
|
12.79
|
|
02 Jul 2025
|
12.90
|
|
01 Jul 2025
|
11.95
|
|
30 Jun 2025
|
11.52
|
|
27 Jun 2025
|
11.74
|
|
26 Jun 2025
|
11.80
|
|
25 Jun 2025
|
11.37
|
|
24 Jun 2025
|
11.60
|
|
23 Jun 2025
|
11.64
|
|
20 Jun 2025
|
12.41
|
|
18 Jun 2025
|
12.58
|
|
17 Jun 2025
|
12.65
|
|
16 Jun 2025
|
12.12
|
|
13 Jun 2025
|
12.07
|
|
12 Jun 2025
|
12.00
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 